Price control, ad-hoc regulatory changes may hamper pharma sector growth: Pfizer
Pfizer fears that the pharma industry is expected to face challenges from price controls, ad-hoc regulatory changes and new policies that may impact sustainable growth.
from The Financial ExpressThe Financial Express https://ift.tt/2wzyAIt
via IFTTT
from The Financial ExpressThe Financial Express https://ift.tt/2wzyAIt
via IFTTT